Leonard Izzard
Deakin University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Leonard Izzard.
Journal of Virology | 2013
Cameron R. Stewart; Glenn A. Marsh; Kristie Jenkins; Michael P. Gantier; Mark Tizard; Deborah Middleton; John W. Lowenthal; Jessica Haining; Leonard Izzard; Tamara J. Gough; Celine Deffrasnes; John Stambas; Rachel Robinson; Hans G. Heine; Jackie Pallister; Adam J. Foord; Andrew G. D. Bean; Lin-Fa Wang
ABSTRACT Hendra virus is a highly pathogenic zoonotic paramyxovirus in the genus Henipavirus. Thirty-nine outbreaks of Hendra virus have been reported since its initial identification in Queensland, Australia, resulting in seven human infections and four fatalities. Little is known about cellular host factors impacting Hendra virus replication. In this work, we demonstrate that Hendra virus makes use of a microRNA (miRNA) designated miR-146a, an NF-κB-responsive miRNA upregulated by several innate immune ligands, to favor its replication. miR-146a is elevated in the blood of ferrets and horses infected with Hendra virus and is upregulated by Hendra virus in human cells in vitro. Blocking miR-146a reduces Hendra virus replication in vitro, suggesting a role for this miRNA in Hendra virus replication. In silico analysis of miR-146a targets identified ring finger protein (RNF)11, a member of the A20 ubiquitin editing complex that negatively regulates NF-κB activity, as a novel component of Hendra virus replication. RNA interference-mediated silencing of RNF11 promotes Hendra virus replication in vitro, suggesting that increased NF-κB activity aids Hendra virus replication. Furthermore, overexpression of the IκB superrepressor inhibits Hendra virus replication. These studies are the first to demonstrate a host miRNA response to Hendra virus infection and suggest an important role for host miRNAs in Hendra virus disease.
PLOS Biology | 2016
Meagan McMahon; Siying Ye; Leonard Izzard; Daniel Dlugolenski; Ralph A. Tripp; Andrew G. D. Bean; Daniel R. McCulloch; John Stambas
The extracellular matrix (ECM) provides physical scaffolding for cellular constituents and initiates biochemical and biomechanical cues that are required for physiological activity of living tissues. The ECM enzyme ADAMTS5, a member of the ADAMTS (A Disintegrin-like and Metalloproteinase with Thrombospondin-1 motifs) protein family, cleaves large proteoglycans such as aggrecan, leading to the destruction of cartilage and osteoarthritis. However, its contribution to viral pathogenesis and immunity is currently undefined. Here, we use a combination of in vitro and in vivo models to show that ADAMTS5 enzymatic activity plays a key role in the development of influenza-specific immunity. Influenza virus infection of Adamts5-/- mice resulted in delayed virus clearance, compromised T cell migration and immunity and accumulation of versican, an ADAMTS5 proteoglycan substrate. Our research emphasises the importance of ADAMTS5 expression in the control of influenza virus infection and highlights the potential for development of ADAMTS5-based therapeutic strategies to reduce morbidity and mortality.
Journal of General Virology | 2014
Leonard Izzard; Siying Ye; Kristie Jenkins; Yingju Xia; Mark Tizard; John Stambas
Difficulties associated with efficient delivery and targeting of miRNAs to cells is hampering the real world application of miRNA technology. This study utilized an influenza A-based delivery system to express miR-155 in order to knockdown SOCS1 mRNA. Using qPCR and dual luciferase technology we show that miR-155 delivery resulted in a significant increase in cellular miR-155 which facilitated a downregulation of SOCS1 gene expression and a functional increase in IL-6 and IFN-β cytokines.
Virus Research | 2017
Leonard Izzard; Daniel Dlugolenski; Yingju Xia; Meagan McMahon; Deborah Middleton; Ralph A. Tripp; John Stambas
Archive | 2014
Ralph A. Tripp; Jon Karpilow; Abhijeet Bakre; Aideen Long; Amanda Birmingham; Andreas Kaufmann; Andrew G. D. Bean; Anja van Brabant Smith; Annaleen Vermeulen; Arvind Rao; Cameron R. Stewart; Caroline E. Shamu; Esther Schmidt; Geoffrey Bartholomeusz; H. J. Kim; Iain D. C. Fraser; Jennifer A. Smith; Jin Y. Kim; Jinyeoung Heo; John Stambas; John W. Lowenthal; Karol Kozak; Kaylene J. Simpson; Kristie Jenkins; Leonard Izzard; Mark Tizard; Michael Adsetts Edberg Hansen; Michael Boutros; Michael Freeley; Michael Banos
Journal of Immunology | 2016
Yingju Xia; Leonard Izzard; Siying Ye; John Stambas
British Journal Virology | 2015
Leonard Izzard; John Stambas
Archive | 2014
Cameron R. Stewart; S. Mark Tompkins; Kristie Jenkins; Leonard Izzard; John Stambas; Andrew G.D. Bean; Mark Tizard; Timothy J. Doran; John W. Lowenthal
Future Virology | 2014
Leonard Izzard; Ralph A. Tripp; John Stambas
Proceedings of the 100th Annual Meeting of the American Association of Immunologists | 2013
John Stambas; Kristie Jenkins; Mark Tizard; Leonard Izzard